CFO4Life Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
1,828
-28
| -2% | -$21.8K | 0.22% | 59 |
|
|
2025
Q1 | $1.53M | Buy |
1,856
+816
| +78% | +$674K | 0.26% | 56 |
|
|
2024
Q4 | $803K | Buy |
1,040
+34
| +3% | +$26.3K | 0.14% | 83 |
|
|
2024
Q3 | $891K | Buy |
1,006
+21
| +2% | +$18.6K | 0.16% | 77 |
|
|
2024
Q2 | $892K | Buy |
985
+65
| +7% | +$58.9K | 0.17% | 68 |
|
|
2024
Q1 | $716K | Sell |
920
-50
| -5% | -$38.9K | 0.13% | 91 |
|
|
2023
Q4 | $565K | Sell |
970
-254
| -21% | -$148K | 0.11% | 106 |
|
|
2023
Q3 | $657K | Buy |
1,224
+426
| +53% | +$229K | 0.15% | 80 |
|
|
2023
Q2 | $374K | Buy |
+798
| New | +$374K | 0.08% | 118 |
|